Hardman Johnston Global Advisors LLC Astrazeneca PLC Transaction History
Hardman Johnston Global Advisors LLC
- $1.99 Billion
- Q4 2025
A detailed history of Hardman Johnston Global Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 546,923 shares of AZN stock, worth $48.9 Million. This represents 2.45% of its overall portfolio holdings.
Number of Shares
546,923
Previous 561,582
2.61%
Holding current value
$48.9 Million
Previous $43.1 Million
13.49%
% of portfolio
2.45%
Previous 2.18%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,548Shares Held
503MCall Options Held
5.54MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...